This webcast originally aired as a live webinar on
January 8, 2013. Dr. Michael King describes approaches currently being used to
isolate circulating tumor cells (CTCs), which are shed into the bloodstream from
primary and metastatic cancers. King describes the limitations of existing CTC
detection technologies, and current strategies being used to overcome them. You
will also hear what isolation of these cells could mean for clinical research
and the future of cancer therapy, as well as a technique for isolation of these
cells developed by Cornell researchers that you can use in your lab.